Hemangiomas and vascular malformations: Unapproved treatments

Clinics in Dermatology

Volumn 20, Issue 6, 2002, Pages 660-667

  Zvulunov, Alex ^a,b,c   Metzker, Aryeh ^a,b,c  

^a Clalit Health Services   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIFIBRINOLYTIC AGENT; BLEOMYCIN; BLEOMYCIN A5; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETHANOLAMINE; ETHIBLOC; MORRHUATE SODIUM; PENTOXIFYLLINE; POLIDOCANOL; PREDNISONE; PROCOAGULANT; TRANEXAMIC ACID; VINCRISTINE;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURGERY; COMPRESSION THERAPY; CONGENITAL BLOOD VESSEL MALFORMATION; CRYOSURGERY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HEMANGIOMA; HUMAN; IONIZING RADIATION; LASER SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SIDE EFFECT;

EID: 0036864110     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00287-0     Document Type: Article

References (92)

1. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children a classification based on endothelial cell characteristics . Plast Reconst Surg. 12:1982;412-420.
2. Enjolras O., Mulliken J.B. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 13:1998;375-423.
3. Enjolras O., Riche M.C., et al. Management of alarming hemangiomas in infancy a review of 25 cases . Pediatrics. 85:1990;491-498.
4. Nauck M., Karakiulakis G., Perruchoud A.P., et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 341:1998;309-315.
5. Blei F. New clinical observations in hemangiomas. Sem Cutan Med Surg. 18:1999;187-194.
6. Bennett M.L., Fleisher A.B., Chamlin S.L., et al. Oral corticosteroid use is effective for cutaneous hemangiomas An evidence-based evaluation . Arch Dermatol. 2001;137.
7. Sadan N., Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr. 128:1996;141-146.
8. Akyuz C., Yaris N., Kutluk M.T., et al. Management of cutaneous hemangiomas a retrospective analysis of 1109 cases and comparison of conventional dose prednisolone with high-dose methylprednisolone therapy . Pediatr Hematol Oncol. 18:2001;47-55.
9. Kim H.J., Colombo M., Frieden I.J. Ulcerated hemangiomas clinical characteristics and response to therapy . J Am Acad Dermatol. 44:2001;962-972.
10. Stratte E.G., Tope W.D., Johnson C.L., et al. Modal management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol. 34:1996;337-342.
11. Hurvitz S.A., Hurvitz C.H., Sloninsky L., et al. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol. 22:2000;527-532.
12. Beaubien E.R., Ball N.J., Storwick G.S. Kaposiform hemangioendothelioma a locally aggressive vascular tumor . J Am Acad Dermatol. 38:1998;799-802.
13. Park E.A., Seo J.W., Lee S.W., et al. Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy. J Korean Med Sci. 16:2001;127-129.
14. Shin H.Y., Ryu K.H., Ahn H.S. Stepwise multimodal approach in the treatment of Kasabach-Merritt syndrome. Pediatr Int. 42:2000;620-624.
15. Hall G.W. Kasabach-Merritt syndrome pathogenesis and management . Br J Haematol. 112:2001;851-862.
16. Gangopadhyay A.N., Sharma S.P., Gopal S.C., et al. Oral steroid therapy in cutaneous hemangiomas. Indian Pediatr. 33:1996;31-33.
17. Chen M.T., Yeong E.K., Horng S.Y. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas a review of 155 cases . J Pediatr Surg. 35:2000;420-423.
18. Chowdri N.A., Darzi M.A., Fazili Z., et al. Intralesional corticosteroid therapy for childhood cutaneous hemangiomas. Ann Plast Surg. 33:1994;46-51.
19. Elsas F.J., Lewis A.R. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus. 31:1994;153-156.
20. Cruz O.A., Zarnegar S.R., Myers S.E. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology. 102:1995;2012-2015.
21. Drolet B.A., Esterly N.B., Frieden I.J. Hemangiomas in children. N Engl J Med. 341:1999;173-181.
22. Bielenberg D.R., Bucana C.D., Sanchez R., et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol. 14:1999;401-408.
23. Garmendia G., Miranda N., Borroso S., et al. Regression of infancy hemangiomas with recombinant IFN-alpha 2b. J Interferon Cytokine Res. 21:2001;31-38.
24. Rampini E., Rampini P., Occella C., et al. Interferon alpha 2b for treatment of complex cutaneous haemangiomas of infancy a reduced dosage schedule . Br J Dermatol. 142:2000;189-191.
25. Tamayo L., Ortiz D.M., Orozco-Covarrubias L., et al. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. Arch-Dermatol. 133:1997;1567-1571.
26. Dubois J., Hershon L., Carmant L., et al. Toxicity profile of interferon alpha-2b in children a prospective evaluation . J Pediatr. 135:1999;782-785.
27. Barlow C.F., Priebe C.J., Mulliken J.B., et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr. 132:1998;527-530.
28. Anger J., Carneiro R.G., Pinus J., et al. The rebound effect in the treatment of complex hemangioma with interferon alpha 2A. Rev Paul Med. 116:1998;1826-1828.
29. Illum N., Karlsmark T., Svejgaard E., et al. Ulcerated haemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor. Dermatology. 191:1995;315-317.
30. Wilmer A., Kaatz M., Bocker T., et al. Tufted angioma. Eur J Dermatol. 9:1999;51-53.
31. Rodriguez-Galindo C., Ramsey K., Jenkins J.J., et al. Hemangiopericytoma in children and infants. Cancer. 88:2000;198-204.
32. Turner C., Gross S. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. Am J Pediatr Hematol Oncol. 16:1994;325-328.
33. Kullendorff C.M. Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int. 12:1997;526-528.
34. Sarihan H., Mocan H., Yildiz K., et al. A new treatment with bleomycin for complicated cutaneous hemangioma in children. Eur J Pediatr Surg. 7:1997;158-162.
35. Oxford A., Barker A., Thonell S., et al. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 30:1995;1282-1287.
36. Boehm D.K., Kobrinsky N.L. Treatment of cavernous hemangioma with vincristine. Ann Pharmacother. 27:1993;981.
37. Perez Payarols J., Pardo Masferrer J., Gomez Bellvert C. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med. 333:1995;69.
38. Wu L., Sun G. Treatment of Hemangioma with an Angiogenesis Inhibitor Pingyangmycin. Ind Pediatr. 37:2000;636-639.
39. Zhong G., Ma Q., Shao Z. Inner-hemangioma ligation and pingyangmycin injection in hemangioma (with 30 cases report). Zhonghua Zheng Xing Wai Ke Za Zhi. 16:2000;133-135.
40. Enjolras O., Wassef M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do not have"true" hemangiomas. J Pediatr. 130:1997;631-640.
41. Smith S.W., Carruthers J.D.A. Intractable periocular hemangioma of infancy. Can J Ophthalmol. 20:1985;220-224.
42. Morad A.B., McClain K.L., Ogden A.K. The role of tranexamic acid in the treatment of giant hemangiomas in newborns. Am J Pediatr Hematol Oncol. 15:1993;383-385.
43. Hanna B.D., Bernstein M. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. Am J Pediatr Hematol Oncol. 11:1989;191-195.
44. De Prost Y., Teillac D., Bodemer C., et al. successful treatment of Kasabach-Merritt syndrome with pentoxifylline. J Am Acad Dermatol. 25:1991;854-855.
45. Doi O., Takada Y. Kasabach-Merritt syndrome in two neonates. J Pediatr Surg. 27:1992;1057-1058.
46. Fox H. Congenital abnormalities. Fox H., Storrs R.S. Diseases of the skin in infancy and childhood. 1930;1-13 Appleton & Co, New York.
47. Kohout M.P., Hansen M., Pribaz J.J., et al. Arteriovenous malformations of the head and neck natural history and management . Plast Reconstr Surg. 102:1998;643-654.
48. Drolet B.A., Scott L.A., Esterly N.B., et al. Early surgical intervention in a patient with Kasabach-Merritt phenomenon. J Pediatr. 138:2001;756-758.
49. Servelle M. Klippel and Trenaunay's syndrome 768 operated cases . Ann Surg. 201:1985;365-373.
50. Pitanguy I., Machado B.H., Radwanski H.N., et al. Surgical treatment of hemangiomas of the nose. Ann Plast Surg. 36:1996;586-593.
51. Jackson I.T., Sosa J. Excision of nasal tip hemangioma via open rhinoplasty - a skin sparing technique. Eur J Plast Surg. 21:1998;265-268.
52. Lundell M., Furst C.J., Hedlund B., et al. Radium treatment for hemangioma in early childhood. Reconstruction and dosimetry of treatments, 1920-1959 . Acta Oncol. 29:1990;551-556.
53. Braun-Falco O., Schultze U., Meinhof W., et al. Contact radiotherapy of cutaneous hemangiomas therapeutic effects and radiation sequelae in 818 patients . Arch Dermatol Res. 253:1975;237-247.
54. Mitsuhashi N., Furuta M., Sakurai H., et al. Outcome of radiation therapy for patients with Kasabach-Merritt syndrome. Int J Radiat Oncol Biol Phys. 39:1997;467-473.
55. Ogino I., Torikai K., Kobayasi S., et al. Radiation therapy for life- or function-threatening infant hemangioma. Radiology. 218:2001;834-839.
56. Benjamin B. Treatment of infantile subglottic hemangioma with radioactive gold grain. Ann Otol Rhinol Laryngol. 87:1978;18-21.
57. Donaldson S.S., Chassagne D., Sancho-Garnier H., et al. Hemangiomas of infancy results of 90Y interstitial therapy: a retrospective study . Int J Radiat Oncol Biol Phys. 5:1979;1-11.
58. Oshiumi Y., Ichiya Y., Shiokawa H., et al. Treatment of skin hemangioma with 90 Sr beta-ray. Rinsho Hoshasen. 21:1976;785-790.
59. Kolinska J., Oppelt A., Sliz K., et al. Clinical experience with the therapy of lateral hemangioma using applicators with radioactive phosphorus. Radiobiol Radiother (Berl). 11:1970;35-40.
60. Ashizawa A., Kono T., Taura T. Electron beam therapy of hemangioma. Rinsho Hoshasen. 15:1970;518-527.
61. Esterly N.B. Hemangiomas. Harper J., Oranje A., Prose N. Textbook of pediatric dermatology. 2000;997-1016 Blackwell Science, Oxford.
62. Bassukas I.D., Abuzahra F., Hundeiker M. Regression phase as therapeutic goal of cryosurgical treatment of growing capillary infantile hemangiomas. Treatment decision, treatment strategy and results of an open clinical study. Hautarzt. 51:2000;231-238.
63. Reischle S., Schuller-Petrovic S. Treatment of capillary hemangiomas of early childhood with a new method of cryosurgery. J Am Acad Dermatol. 42:2000;809-813.
64. Michel S., Wlotzke U., Hohenleutner U., et al. Laser and cryotherapy of hemangioma in infants in a direct comparison. Hautarzt. 49:1998;192-196.
65. Staindl O. Treatment of hemangiomas of the face with magnesium seeds. Arch Otorhinolaryngol. 246:1989;213-217.
66. Wang D. Retained copper needles for the treatment of cavernous hemangioma. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 9:1993;321-396.
67. Shafranov V.V., Poliaev I.A., Konstantinov K.V., et al. Use of ultra high-frequency electromagnetic fields in pediatric surgery. Vestn Ross Akad Med Nauk. 3:1994;23-25.
68. Tan O.T., Sherwood K., Gilchrest B.A. Treatment of children with port-wine stains using flashlamp-pulsed tunable dye laser. N Engl J Med. 320:1989;416-421.
69. Pickering J.W., Walker E.P., Butler P.H., et al. Copper vapor laser treatment of port-wine stains and other vascular malformations. Br J Plast Surg. 43:1990;273-282.
70. Sheehan-Dare R.A., Cotterill J.A. Copper vapour laser (578 nm) and flashlamp-pumped pulsed tunable dye laser (585 nm) treatment of port wine stains results of a comparative study using test sites . Br J Dermatol. 130:1994;478-482.
71. Ashinof R., Geronemus R.G. Flashlamp-pumped pulsed dye laser for port-wine stains in infancy earlier versus later treatment . J Am Acad Dermatol. 24:1991;467-472.
72. Jacob R., Frommeld T., Maurer J., et al. Duplex ultrasonography-controlled Nd:Yag laser therapy of vascular malformations. Ultraschall Med. 20:1999;191-196.
73. Dummer R., Graf P., Greif C., et al. Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium:YAG laser. Dermatology. 197:1998;158-161.
74. Achauer B.M., Chang C.J., Vander-Kam V.M. Management of hemangioma of infancy review of 245 patients . Plast Reconstr Surg. 99:1997;1301-1308.
75. Hohenleutner S., Badur-Ganter E., Landthaler M. Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser an evaluation of 617 cases . Lasers Surg Med. 28:2001;273-277.
76. Poetke M., Philipp C., Berlien H.P. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy treatment of superficial vs mixed hemangiomas . Arch Dermatol. 136:2000;628-632.
77. Morelli J.G., Tan O.T., Weston W.L. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am J Dis Child. 145:1991;1062-1064.
78. Cho S., Lee S.Y., Choi J.H., et al. Treatment of "Cyrano" angioma with pulsed dye laser. Dermatol Surg. 27:2001;670-672.
79. Achauer B.M., Chang C.J., VanderKam V.M., et al. Intralesional photocoagulation of periorbital hemangiomas. Plast Reconstr Surg. 103:1999;11-19.
80. Burstein F.D., Simms C., Cohen S.R., et al. Intralesional laser therapy of extensive hemangiomas in 100 consecutive pediatric patients. Ann Plast Surg. 44:2000;188-194.
81. Angermeier M.C. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther. 1:1999;95-100.
82. Lin X.X., Wang W., Wu S.F., et al. Treatment of capillary vascular malformation (port-wine stains) with photochemotherapy. Plast Reconstr Surg. 99:1997;1826-1830.
83. Komiyama M., Nakajima H., Kitano S., et al. Endovascular treatment of huge cervicofacial hemangioma complicated by Kassabach-Merrit syndrome. Pediatr Neurosurg. 33:2000;26-30.
84. Jackson I.T., Correno R., Potparic R., et al. Hemangiomas, vascular malformations and lymphovenous malformations classification and methods of treatment . Plast Reconstr Surg. 91:1993;1216-1230.
85. Lopez-Gutierrez J.C., Ros Z., Perez-Higueras A. Giant vascular malformation of the face in a premature infant complete resolution by embolization . J Pediatr Surg. 30:1995;1519-1520.
86. Tonner P.H., Scholz J. Possible lung embolism following embolization of a hemangioma with fibrin glue. Anaesthesist. 43:1994;614-617.
87. Donaldson J.S., Morello F.P., et al. Symptomatic hemangiomas and venous malformations in infants, children, and young adults treatment with percutaneous injection of sodium tetradecyl sulfate . Am J Roentgenol. 169:1997;723-729.
88. Breviere G.M., Bonnevalle M., Pruvo J.P., et al. Use of Ethibloc in the treatment of cystic and venous angiomas in children 19 cases . Eur J Pediatr Surg. 3:1993;166-170.
89. de-Lorimier A.A. Sclerotherapy for venous malformations. J Pediatr Surg. 30:1995;188-194.
90. Winter H., Drager E., Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg. 26:2000;105-108.
91. Stringel G., Dastous J. Klippel-Trenaunay syndrome and other cases of lower limb hypertrophy pediatric surgical implications . J Pediatr Surg. 22:1987;645-650.
92. Kaplan M., Paller A.S. Clinical pearl: use of self-adhesive, compressive wraps in the treatment of limb hemangiomas. J Am Acad Dermatol. 32:1995;117-118.